The question industry leaders are asking is: Has the life sciences industry reached a turning point? After several turbulent years, the number of bankruptcies among public life sciences companies declined in 2025 from 2024. This decline could mark the beginning of a major economic shift for the industry. However, life sciences is a cyclical industry, and hot markets can easily cool again. Performance across the industry can also vary significantly in specific markets and subsectors. For example, the upturn in 2026 is less pronounced among early-stage life sciences companies, many of whom are still struggling to survive. Regardless of how external circumstances evolve over the rest of this year, however, life sciences is and will remain a high-risk industry.
Read the full article: Life Sciences Resilience Report //
Source: https://www.lexology.com/library/detail.aspx?g=7043f1e2-74b8-4f0d-89c7-6514f75a45a6